Summary of data obtained from donors with primary CMV infections
. | Donor 1 . | . | Donor 2 . | . | Donor 3 . | . | Donor 4 . | . | Donor 5 . | . | Donor 6 . | . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | Tetr+ . | IL-7Rα+ . | Tetr+ . | IL-7Rα+ . | Tetr+ . | IL-7Rα+ . | Tetr+ . | IL-7Rα+ . | Tetr+ . | IL-7Rα+ . | Tetr+ . | IL-7Rα+ . | ||||||
| During positive PCR, % | 1.8 | 0.4 | 4.9 | 0.4 | 0.7 | 1.1 | 0.6 | 2.2 | 6.4 | 1.5 | 1.0 | 1.1 | ||||||
| 1 y after transplantation, % | 0.3 | 7.8 | 2.3 | 3.9 | 0.5 | 2.2 | 0.5 | 4.9 | 4.0 | 7.5 | 0.5 | 3.9 | ||||||
| More than 2 y after transplantation, % | 0.9 | 17.2 | NA | NA | NA | NA | NA | NA | 2.9 | 10.1 | 2.0 | 4.9 | ||||||
. | Donor 1 . | . | Donor 2 . | . | Donor 3 . | . | Donor 4 . | . | Donor 5 . | . | Donor 6 . | . | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
. | Tetr+ . | IL-7Rα+ . | Tetr+ . | IL-7Rα+ . | Tetr+ . | IL-7Rα+ . | Tetr+ . | IL-7Rα+ . | Tetr+ . | IL-7Rα+ . | Tetr+ . | IL-7Rα+ . | ||||||
| During positive PCR, % | 1.8 | 0.4 | 4.9 | 0.4 | 0.7 | 1.1 | 0.6 | 2.2 | 6.4 | 1.5 | 1.0 | 1.1 | ||||||
| 1 y after transplantation, % | 0.3 | 7.8 | 2.3 | 3.9 | 0.5 | 2.2 | 0.5 | 4.9 | 4.0 | 7.5 | 0.5 | 3.9 | ||||||
| More than 2 y after transplantation, % | 0.9 | 17.2 | NA | NA | NA | NA | NA | NA | 2.9 | 10.1 | 2.0 | 4.9 | ||||||
Tetr+ indicates percentages of CMV-specific cells within CD8+ T cells; IL-7Rα+, percentages of CMV-specific cells expressing IL-7Rα; positive PCR, time point during positive CMV PCR; NA, not available.
Donor 1 is the donor shown in Figure 1A.